Blog - Announcements

Vasomedical to Report Fourth Quarter and Fiscal Year 2014 Results on March 30, 2015

Management to Hold Investor Conference Call on March 30, 2015 at 11:00 a.m. ET

WESTBURY, NY / ACCESSWIRE / March 23, 2015 / Vasomedical, Inc. (OTCQB:VASO) announces today that it will release its financial results for the three months and year ended December 31, 2014 on Monday, March 30, 2015.

The Company will host a conference call on Monday, March 30, 2015 at 11:00 a.m. ET featuring remarks by Jun Ma, Ph.D., President and CEO of Vasomedical, and Michael Beecher, Chief Financial Officer of Vasomedical. To join the conference call, please dial 1-877-407-8033 from the U.S. or 1-201-689-8033, internationally. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vasomedical’s website, Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

A replay of the conference call will be available approximately two hours after completion of the live conference call at To access the dial-in replay of the call, which will be available until June 30th, 2015, please dial 1-877-660-6853 or 1-201-612-7415. All dial-in participants must use the following code to access the call: 13604624.

About Vasomedical

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products. The Company operates through four wholly owned subsidiaries: Vasomedical Solutions, Inc., Vasomedical Global Corp., Vaso Diagnostics, Inc. d.b.a. VasoHealthcare, and VasoHealthcare IT Corp. Vasomedical Solutions manages and coordinates the design, manufacture and sales of EECP(R) Therapy systems and other medical equipment operations; Vasomedical Global operates the Company’s China-based subsidiaries; VasoHealthcare is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments; and VasoHealthcare IT is a national value added reseller of GE Healthcare IT’s Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support. Additional information is available on the Company’s website at

Investor Contacts:

Michael Beecher / Amanda Jiang
Investor Relations
516-508-5840 /

SOURCE: Vasomedical, Inc.

Link to Accesswire: